Skip to content
healthcare.dev

Levothyroxine Sodium

NDC 63323-895, Levothyroxine Sodium, injection, solution, from Fresenius Kabi USA, LLC.

Product NDC
63323-895
Status
Listed
Labeler
Fresenius Kabi USA, LLC
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA210632
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/63323-895 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LEVOTHYROXINE SODIUM100 ug/mL

Pharmacologic classes

Thyroxine [CS]; l-Thyroxine [EPC]

Package NDCNDC-11Package
63323-895-10633230895101 VIAL, SINGLE-DOSE in 1 CARTON (63323-895-10) / 5 mL in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/08f4b1f8-6807-47e7-bef8-8d1972aa0557
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=63323-895

Use it

Look up 63323-895 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/63323-895 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 63323-895. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.